Brief: POINT Biopharma To Publish Abstract At ESMO Congress 2022
Aug 18 (Reuters) - POINT Biopharma Global Inc PNT.O :
* POINT BIOPHARMA TO PUBLISH ABSTRACT AT ESMO CONGRESS 2022
CONTAINING EFFICACY & SAFETY DATA FROM LEAD-IN COHORT OF PHASE 3
SPLASH TRIAL
Source text for Eikon: ID:nGNX6vyz0K
Further company coverage: PNT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on POINT Biopharma Global
See all newsBrief: Eli Lilly Completes Acquisition Of POINT Biopharma
Fusion Pharma gains on Bristol Myers-RayzeBio deal
Brief: Point Biopharma- Lilly Offer Expired And Not Further Extended - SEC Filing
Brief: BVF Partners Dissolves Share Stake In Point Biopharma Global
U.S. STOCKS ON THE MOVE-Biomerica, Netflix, SunPower